-
Semgo 7mg (Semaglutide) is an FDA-approved oral medication designed to manage Type 2 Diabetes Mellitus (T2DM) promote effective weight loss and reduce the risk of chronic kidney disease and cardiovascular events. Convenient and effective it is part of the only Semaglutide pill approved since September 2019 for adult patients. -
Semgo 14mg (Semaglutide) is an FDA approved oral medication used to manage Type 2 Diabetes Mellitus (T2DM) promote weight loss and reduce the risk of chronic kidney disease and major cardiovascular events. Available in 3mg 7mg and 14mg doses Semgo 14mg is effective in long term blood sugar control and overall health improvement. -
Start your semaglutide journey the right way. Semgo Injection 0.25mg is the medically recommended initiation dose — a once-weekly pre-filled syringe that gently introduces GLP-1 therapy to your body. Ideal for adults beginning treatment for Type 2 Diabetes or weight management. Manufactured by Cell Laboratories (Pvt.) Ltd. -
Step up your semaglutide treatment with confidence. Semgo Injection 0.5mg is the first therapeutic dose — a once-weekly pre-filled syringe that begins delivering real, measurable results for blood sugar control and weight loss. Prescribed for adults progressing from the 0.25mg initiation dose. Manufactured by Cell Laboratories (Pvt.) Ltd. -
This is where long-term results are maintained. Semgo Injection 1mg is the full maintenance dose of semaglutide — a once-weekly pre-filled syringe delivering maximum therapeutic benefit for blood sugar control, weight management, and cardiovascular protection. For adults who have completed the titration schedule. Manufactured by Cell Laboratories (Pvt.) Ltd.






